Today's edition · Sunday, November 22, 2026
Every story verifiedNo politics. Ever.No pop-ups
TodayLocalWorldHeroesAnimalsScienceCommunityHealth & TechMapQuizKindnessAnnouncementsKidsTopicsExplainersOn this dayCalendarGood NeighborHometown Heroes

TodayHealth & Tech

Health & Tech

Health & Tech good news

Medical advances and useful technology already helping people, or shown in human trials. Verified good news, each story linked to its original source.

Browse by state

Health & Tech by state

Browse by country

A row of glass laboratory beakers on a white surfaceHealth & Tech
Silver Spring, Maryland

The FDA approved a pre-surgery bladder cancer combo

The FDA approved durvalumab, sold as Imfinzi, plus enfortumab vedotin before bladder removal, then durvalumab afterward, for muscle-invasive bladder cancer in patients who cannot take cisplatin or who decline it. In the 695-patient VOLGA trial the combo cut the risk of an event by about half. It is not a cure.

Verified · U.S. Food and Drug Administration
A scientist in a white coat working with sample tubes at a laboratory benchHealth & Tech
Silver Spring, Maryland

The FDA approved the first drug for a rare kidney disease

The FDA approved Gazyva, obinutuzumab, for adults with primary membranous nephropathy at risk of getting worse, to induce remission of protein in the urine. In a 142-person trial, 36 percent reached complete remission at week 104, compared with 6 percent on tacrolimus. It is not a cure.

Verified · U.S. Food and Drug Administration